IRISYS: Moving beyond just solid dose, Recro Pharma is headed to San Diego with acquisition

Pennsylvania-based CDMO Recro Pharma is expanding to the West Coast with the acquisition of Irisys, a San Diego CDMO. The company announced the deal Friday. Recro bought Irisys for about $50 million in cash, shares and a promissory note. Irisys can commercially manufacture oral liquids, sterile injectables, tablets, topicals, liquid-...